Skip to main content
Top
Published in: Osteoporosis International 6/2018

01-06-2018 | Original Article

After the fall: improving osteoporosis treatment following hip fracture

Authors: B. W. Kuiper, S. Graybill, J. M. Tate, N. Kaufman, D. Bersabe

Published in: Osteoporosis International | Issue 6/2018

Login to get access

Abstract

Summary

Osteoporotic hip fractures can be life changing and can increase mortality. Treatment of osteoporosis following hip fracture is often delayed. We began offering osteoporosis medication during hospitalization for hip fracture, dramatically increasing the number of patients meeting standard of care.

Introduction

Osteoporotic hip fracture is a debilitating condition with major morbidity and mortality implications. Osteoporosis medication given within 90 days of hip fracture improves mortality and reduces risk of future fractures. The aim of this project was to improve rates of timely osteoporosis treatment following fragility hip fracture.

Methods

This was a two-step intervention utilizing the Plan-Do-Study-Act cycle, beginning with resident-focused education in cycle 1. In cycle 2, we offered osteoporosis medication to inpatients for hip fracture with help from a new electronic order set.

Results

Prior to this intervention, 32% of patients received osteoporosis medication within 90 days of fragility hip fracture; this improved to 81% after intervention.

Conclusions

Resident education and an electronic order set dramatically improved the percentage of patients meeting standard of care with osteoporosis pharmacotherapy following fragility fracture.
Literature
1.
go back to reference Cosman F, de Beur SJ, LeBoff M, Lewiecki EM, Tanner B, Randall S, Lindsay R, National Osteoporosis Foundation (2014) Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int 25(10):2359–2381CrossRefPubMedPubMedCentral Cosman F, de Beur SJ, LeBoff M, Lewiecki EM, Tanner B, Randall S, Lindsay R, National Osteoporosis Foundation (2014) Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int 25(10):2359–2381CrossRefPubMedPubMedCentral
2.
go back to reference Abrahamsen B, van Staa T, Ariely R, Olson M, Cooper C (2009) Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int 20(10):1633–1650CrossRefPubMed Abrahamsen B, van Staa T, Ariely R, Olson M, Cooper C (2009) Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int 20(10):1633–1650CrossRefPubMed
3.
go back to reference Lyles KW, Colón-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C, Hyldstrup L, Recknor C, Nordsletten L, Moore KA, Lavecchia C, Zhang J, Mesenbrink P, Hodgson PK, Abrams K, Orloff JJ, Horowitz Z, Eriksen EF, Boonen S, HORIZON Recurrent Fracture Trial (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357(18):1799–1809CrossRefPubMed Lyles KW, Colón-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C, Hyldstrup L, Recknor C, Nordsletten L, Moore KA, Lavecchia C, Zhang J, Mesenbrink P, Hodgson PK, Abrams K, Orloff JJ, Horowitz Z, Eriksen EF, Boonen S, HORIZON Recurrent Fracture Trial (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357(18):1799–1809CrossRefPubMed
4.
go back to reference Li YT, Cai HF, Zhang ZL (2015) Timing of the initiation of bisphosphonates after surgery for fracture healing: a systematic review and meta-analysis of randomized controlled trials. Osteoporos Int 26(2):431–441CrossRefPubMed Li YT, Cai HF, Zhang ZL (2015) Timing of the initiation of bisphosphonates after surgery for fracture healing: a systematic review and meta-analysis of randomized controlled trials. Osteoporos Int 26(2):431–441CrossRefPubMed
5.
go back to reference Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, Cosman F, Lakatos P, Leung PC, Man Z, Mautalen C, Mesenbrink P, Hu H, Caminis J, Tong K, Rosario-Jansen T, Krasnow J, Hue TF, Sellmeyer D, Eriksen EF, Cummings SR, HORIZON Pivotal Fracture Trial (2007) Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356(18):1809–1822CrossRefPubMed Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, Cosman F, Lakatos P, Leung PC, Man Z, Mautalen C, Mesenbrink P, Hu H, Caminis J, Tong K, Rosario-Jansen T, Krasnow J, Hue TF, Sellmeyer D, Eriksen EF, Cummings SR, HORIZON Pivotal Fracture Trial (2007) Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356(18):1809–1822CrossRefPubMed
6.
go back to reference Gardner MJ, Brophy RH, Demetrakopoulos D, Koob J, Hong R, Rana A, Lin JT, Lane JM (2005) Interventions to improve osteoporosis treatment following hip fracture. A prospective, randomized trial J Bone Joint Surg Am 87(1):3–7 Gardner MJ, Brophy RH, Demetrakopoulos D, Koob J, Hong R, Rana A, Lin JT, Lane JM (2005) Interventions to improve osteoporosis treatment following hip fracture. A prospective, randomized trial J Bone Joint Surg Am 87(1):3–7
9.
go back to reference Drew S et al (2014) Describing variation in the delivery of secondary fracture prevention after hip fracture: an overview of 11 hospitals within one regional area in England. Osteoporos Int 25(10):2427–2433CrossRefPubMedPubMedCentral Drew S et al (2014) Describing variation in the delivery of secondary fracture prevention after hip fracture: an overview of 11 hospitals within one regional area in England. Osteoporos Int 25(10):2427–2433CrossRefPubMedPubMedCentral
10.
go back to reference Taylor MJ, McNicholas C, Nicolay C, Darzi A, Bell D, Reed JE (2014) Systematic review of the application of the plan-do-study-act method to improve quality in healthcare. BMJ Qual Saf 23(4):290–298CrossRefPubMed Taylor MJ, McNicholas C, Nicolay C, Darzi A, Bell D, Reed JE (2014) Systematic review of the application of the plan-do-study-act method to improve quality in healthcare. BMJ Qual Saf 23(4):290–298CrossRefPubMed
11.
go back to reference Solomon DH, Hochberg MC, Mogun H, Schneeweiss S (2009) The relation between bisphosphonate use and non-union of fractures of the humerus in older adults. Osteoporos Int 20(6):895–901CrossRefPubMed Solomon DH, Hochberg MC, Mogun H, Schneeweiss S (2009) The relation between bisphosphonate use and non-union of fractures of the humerus in older adults. Osteoporos Int 20(6):895–901CrossRefPubMed
12.
go back to reference Colón-Emeric C et al (2011) Association between timing of zoledronic acid infusion and hip fracture healing. Osteoporos Int 22(8):2329–2336CrossRefPubMed Colón-Emeric C et al (2011) Association between timing of zoledronic acid infusion and hip fracture healing. Osteoporos Int 22(8):2329–2336CrossRefPubMed
13.
go back to reference Uchiyama S, Itsubo T, Nakamura K, Fujinaga Y, Sato N, Imaeda T, Kadoya M, Kato H (2013) Effect of early administration of alendronate after surgery for distal radial fragility fracture on radiological fracture healing time. The Bone Joint J 95-B:1544–1550CrossRefPubMed Uchiyama S, Itsubo T, Nakamura K, Fujinaga Y, Sato N, Imaeda T, Kadoya M, Kato H (2013) Effect of early administration of alendronate after surgery for distal radial fragility fracture on radiological fracture healing time. The Bone Joint J 95-B:1544–1550CrossRefPubMed
14.
go back to reference Kim T-Y, Ha YC, Kang BJ, Lee YK, Koo KH (2012) Does early administration of bisphosphonate affect fracture healing in patients with intertrochanteric fractures? J Bone Joint Surg 94-B(7):956–960CrossRef Kim T-Y, Ha YC, Kang BJ, Lee YK, Koo KH (2012) Does early administration of bisphosphonate affect fracture healing in patients with intertrochanteric fractures? J Bone Joint Surg 94-B(7):956–960CrossRef
15.
go back to reference Li C, Wang HR, Li XL, Zhou XG, Dong J (2012) The relation between zoledronic acid infusion and interbody fusion in patients undergoing transforaminal lumbar interbody fusion surgery. Acta Neurochir 154(4):731–738CrossRefPubMed Li C, Wang HR, Li XL, Zhou XG, Dong J (2012) The relation between zoledronic acid infusion and interbody fusion in patients undergoing transforaminal lumbar interbody fusion surgery. Acta Neurochir 154(4):731–738CrossRefPubMed
16.
go back to reference Zampelis V et al (2017) Decreased migration with locally administered bisphosphonate in cemented cup revisions using impaction bone grafting technique. Acta Orthop Zampelis V et al (2017) Decreased migration with locally administered bisphosphonate in cemented cup revisions using impaction bone grafting technique. Acta Orthop
17.
18.
go back to reference Camacho P et al (2016) American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the diagnosis and treatment of postmenopausal osteoporosis. Endocr Pract 22:1–42CrossRefPubMed Camacho P et al (2016) American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the diagnosis and treatment of postmenopausal osteoporosis. Endocr Pract 22:1–42CrossRefPubMed
19.
go back to reference Isakova T, Nickolas TL, Denburg M, Yarlagadda S, Weiner DE, Gutiérrez OM, Bansal V, Rosas SE, Nigwekar S, Yee J, Kramer H (2017) KDOQI US Commentary on the 2017 KDIGO clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Am J Kidney Dis 70(6):737–751CrossRefPubMed Isakova T, Nickolas TL, Denburg M, Yarlagadda S, Weiner DE, Gutiérrez OM, Bansal V, Rosas SE, Nigwekar S, Yee J, Kramer H (2017) KDOQI US Commentary on the 2017 KDIGO clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Am J Kidney Dis 70(6):737–751CrossRefPubMed
20.
go back to reference Qaseem A, Forciea MA, McLean RM, Denberg TD, for the Clinical Guidelines Committee of the American College of Physicians (2017) Treatment of low bone density or osteoporosis to prevent fractures in men and women: a clinical practice guideline update from the American College of Physicians. Ann Intern Med 166(11):818–839CrossRefPubMed Qaseem A, Forciea MA, McLean RM, Denberg TD, for the Clinical Guidelines Committee of the American College of Physicians (2017) Treatment of low bone density or osteoporosis to prevent fractures in men and women: a clinical practice guideline update from the American College of Physicians. Ann Intern Med 166(11):818–839CrossRefPubMed
21.
go back to reference Senay A, Delisle J, Giroux M, Laflamme GY, Leduc S, Malo M, Nguyen H, Ranger P, Fernandes JC (2016) The impact of a standardized order set for the management of non-hip fragility fractures in a fracture liaison service. Osteoporos Int 27(12):3439–3447CrossRefPubMedPubMedCentral Senay A, Delisle J, Giroux M, Laflamme GY, Leduc S, Malo M, Nguyen H, Ranger P, Fernandes JC (2016) The impact of a standardized order set for the management of non-hip fragility fractures in a fracture liaison service. Osteoporos Int 27(12):3439–3447CrossRefPubMedPubMedCentral
22.
go back to reference Edwards BJ, Bunta AD, Anderson J, Bobb A, Hahr A, O’Leary KJ, Agulnek A, Andruszyn L, Cameron KA, May M, Kazmers NH, Dillon N, Baker DW, Williams MV (2012) Development of an electronic medical record based intervention to improve medical care of osteoporosis. Osteoporos Int 23(10):2489–2498CrossRefPubMed Edwards BJ, Bunta AD, Anderson J, Bobb A, Hahr A, O’Leary KJ, Agulnek A, Andruszyn L, Cameron KA, May M, Kazmers NH, Dillon N, Baker DW, Williams MV (2012) Development of an electronic medical record based intervention to improve medical care of osteoporosis. Osteoporos Int 23(10):2489–2498CrossRefPubMed
23.
go back to reference Harrington JT, Barash HL, Day S, Lease J (2005) Redesigning the care of fragility fracture patients to improve osteoporosis management: a health care improvement project. Arthritis Rheum 53(2):198–204CrossRefPubMed Harrington JT, Barash HL, Day S, Lease J (2005) Redesigning the care of fragility fracture patients to improve osteoporosis management: a health care improvement project. Arthritis Rheum 53(2):198–204CrossRefPubMed
Metadata
Title
After the fall: improving osteoporosis treatment following hip fracture
Authors
B. W. Kuiper
S. Graybill
J. M. Tate
N. Kaufman
D. Bersabe
Publication date
01-06-2018
Publisher
Springer London
Published in
Osteoporosis International / Issue 6/2018
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-018-4416-x

Other articles of this Issue 6/2018

Osteoporosis International 6/2018 Go to the issue